Skip to content

Barricade Coil System 900100Recalls & reported problems

Balt USA LLC · Barricade Coil System (BCS) is intended for the endovascular embolization of intracranial aneurysms and other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae. The BCS is also intended for vascular occlusion of blood vessels within the neurovascular system to permanently obstruct blood flow to an aneurysm or other vascular malformation and for arterial and venous embolizations in the peripheral vasculature. The BCS consists of an implantable coil attached to a delivery pusher. The delivery pusher is powered by the Blockade Detachment Controller (BDC) designed specifically for the BCS. The device comes pre-loaded with one 9-volt battery. A BlockWire Connecting Cable or Handheld Detachment Cable, comprised of a red and black cable leads are required to detach Barricade Detachable Coils and must be used in conjunction with a return electrode. · Class 2 · Implant

All models of Barricade Coil System (18)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00818053020995), received between Jul 7, 2021 and Jul 7, 2021 — classified as 1 malfunction.

The most frequently reported specific device problem is “Migration” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Migration1
  • Premature Separation1

Patient problems

  • Embolism/Embolus1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJul 7, 2021Migration; Premature Separation; Migration; Premature Separation

    IT WAS REPORTED THAT: "THE PHYSICIAN WHILE TREATING A RUPTURED LEFT ANTERIOR CHOROIDAL ARTERY ANEURYSM, GOT ACCESS USING 7FR LONG SHEATH AND FARGOMAX 105. ACCESSED THE ANEURYSM WITH VASCO 10 MICROCATHETER AND TRAXCESS WIRE. USED ECLIPSE 2L BALLON AS BACKUP SINCE THE ANEURYSM IS RUPTURED ONE.. AFTER ACCESSING THE ANEURYSM STARTED DEPLOYING COILS. USED 6 BARRICADE COILS OF DIFFERENT SIZES. AFTER THAT TOOK DSA AND FOUND THAT THERE IS SOME MORE SPACE TO BE FILLED FOR GETTING A COMPLETE OCCLUSION OF THE ANEURYSM. SO, THE PHYSICIAN DECIDED TO USE BARRICADE HELICAL FINISH 4 X 10 AS THE LAST COIL. WITHOUT ANY ISSUES THE COIL PASSED THROUGH THE CATHETER INTO THE ANEURYSM. AFTER COUPLE OF LOOPS (ALMOST HALF OF THE LENGTH OF THE COIL) WHILE TRYING TO PUSH THE COIL, THE PHYSICIAN NOTICED THAT THE COIL PUSHER WIRE IS FREELY MOVING, BUT THERE IS NO MOVEMENT TO THE COIL. PHYSICIAN SLOWLY TRIED TO PULL BACK THE PUSHER WIRE AT THAT TIME TOO THE WIRE IS COMING BACK FREELY WITH NO INTERACTION WITH THE COIL AND CONFIRMED THAT THE COIL GOT PREMATURE DETACHMENT WITHIN THE MICRO CATHETER ITSELF. AFTER THAT PHYSICIAN SLOWLY PULLED BACK THE MICRO. WHILE DOING THAT THE ENTIRE COIL MASS WAS ALSO MOVING AND A

    Patient problems: Embolism/Embolus

    MAUDE report 12128560 ↗

Other Device, Neurovascular Embolization devices

All Device, Neurovascular Embolization devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page